Published Date: 15 Mar 2023
Since the development of functional magnetic resonance imaging in the 1990s, expectations for neuroimaging have skyrocketed as researchers analyze fMRI data of the resting brain and the body of the brain unique to it.
Read Full NewsA meta-analysis identifies impaired effort-based decision making across psychiatric disorders, pointing to actionable targets for improving motivation and functional outcomes.
Comments on a Medscape feature push past ideology to ask what evidence, oversight, and safeguards should be available for patients who choose assisted death.
Patients aged 70 years or older stand to benefit from adjuvant chemotherapy for triple-negative breast cancer, but the majority do not receive it.
Researchers conducted a systematic review and meta-analysis for studies of acute myeloid leukemia patients with a median age less than 70 treated with HMA plus venetoclax.
Nearly 400 trials and Belgium’s isotope hub signal rapid clinical diversification for radioligand therapy — but policy, funding, and system readiness must follow.
1.
Radiotherapy of cancer: Researchers enable better cancer treatment using existing medical equipment
2.
To refute accusations that it failed to issue a cancer warning, Roundup's maker is asking lawmakers for assistance.
3.
Top 10 questions about breast cancer answered
4.
Telehealth in the pandemic era resulted in fewer therapy interruptions.
5.
A study suggests that you should disregard the "pack-years" when determining your eligibility for lung cancer screening.
1.
Unlocking the Potential of Cancer Antigen 19-9 for Early Detection
2.
Revolutionizing Cancer Treatment with Darzalex: How an Innovative Drug is Transforming Lives
3.
The Growing Crisis of Aplastic Anemia: A Call for Action
4.
Screening Strategies in Oncology: A Subspecialty Guide to Early Detection and Better Outcomes
5.
Exploring Innovative Solutions for Infantile Hemangioma Treatment
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Current Scenario of Blood Cancer- Further Discussion on Genomic Testing & Advancement in Diagnosis and Treatment
2.
Newer Immunotherapies for Myeloma- A Comprehensive Overview
3.
Summary of The Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2
4.
A Panel Discussion on Clinical Trial End Point for Tumor With PPS > 12 months
5.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation